Vanguard Group’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,924,315
| Closed | -$25.4M | – | 4190 |
|
|
2019
Q3 | $25.4M | Buy |
5,924,315
+638,142
| +12% | +$2.32M | ﹤0.01% | 2368 |
|
|
2019
Q2 | $15.8M | Buy |
5,286,173
+1,496,809
| +40% | +$3.75M | ﹤0.01% | 2636 |
|
|
2019
Q1 | $6.59M | Buy |
3,789,364
+1,694,975
| +81% | +$2.34M | ﹤0.01% | 3027 |
|
|
2018
Q4 | $1.76M | Sell |
2,094,389
-1,648,193
| -44% | -$1.97M | ﹤0.01% | 3415 |
|
|
2018
Q3 | $5.31M | Sell |
3,742,582
-79,996
| -2% | -$87.5K | ﹤0.01% | 3214 |
|
|
2018
Q2 | $3.16M | Sell |
3,822,578
-244,015
| -6% | -$235K | ﹤0.01% | 3358 |
|
|
2018
Q1 | $5.57M | Buy |
4,066,593
+149,530
| +4% | +$174K | ﹤0.01% | 3097 |
|
|
2017
Q4 | $3.96M | Buy |
3,917,063
+1,891
| +0% | +$2.14K | ﹤0.01% | 3215 |
|
|
2017
Q3 | $5.95M | Buy |
3,915,172
+635,987
| +19% | +$1.07M | ﹤0.01% | 3047 |
|
|
2017
Q2 | $6.1M | Buy |
3,279,185
+1,198,384
| +58% | +$1.6M | ﹤0.01% | 3017 |
|
|
2017
Q1 | $2.73M | Buy |
2,080,801
+30,492
| +1% | +$24.8K | ﹤0.01% | 3279 |
|
|
2016
Q4 | $1.43M | Buy |
2,050,309
+34,368
| +2% | +$28.9K | ﹤0.01% | 3470 |
|
|
2016
Q3 | $2.24M | Buy |
2,015,941
+81,550
| +4% | +$109K | ﹤0.01% | 3343 |
|
|
2016
Q2 | $2.77M | Buy |
1,934,391
+113,981
| +6% | +$132K | ﹤0.01% | 3243 |
|
|
2016
Q1 | $1.8M | Buy |
1,820,410
+333,170
| +22% | +$572K | ﹤0.01% | 3417 |
|
|
2015
Q4 | $4.77M | Buy |
1,487,240
+257,387
| +21% | +$804K | ﹤0.01% | 3005 |
|
|
2015
Q3 | $3.8M | Buy |
1,229,853
+1,191,128
| +3,076% | +$4.3M | ﹤0.01% | 3095 |
|
|
2015
Q2 | $136K | Buy |
+38,725
| New | +$165K | ﹤0.01% | 4089 |
|
Vanguard Group's CVRS Position: Q4 2019 in Review
Vanguard Group sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 5,924,315 shares — an estimated $25.4M sold.
Vanguard Group first reported a position in CVRS in Q2 2015 and held it in 18 quarters. The position peaked at $25.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Vanguard Group reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Vanguard Group sold 5,924,315 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $25.4M.
- Vanguard Group first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 18 quarters.
- Vanguard Group's CORINDUS VASCULAR ROBOTICS, INC position peaked at $25.4M in Q3 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.